| 1 |
2022 |
Hua Miao, Yamei Zhang, Xiaoyong Yu, Liang Zou, Yingyong Zhao. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy, Frontiers in Pharmacology. 2022; 13: 969930.
https://doi.org/10.3389/fphar.2022.969930 |
| 2 |
2024 |
Na Ren, Wen-Feng Wang, Liang Zou, Yan-Long Zhao, Hua Miao, Ying-Yong Zhao. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis, Frontiers in Pharmacology. 2024; 14: 1335094.
https://doi.org/10.3389/fphar.2023.1335094 |
| 3 |
2024 |
Xiao-Jun Li, Chu Fang, Rui-Hua Zhao, Liang Zou, Hua Miao, Ying-Yong Zhao. Bile acid metabolism in health and ageing-related diseases, Biochemical Pharmacology. 2024; 225: 116313116313.
https://doi.org/10.1016/j.bcp.2024.116313 |
| 4 |
2024 |
G.R. Saranya, Pragasam Viswanathan. Identification of renal protective gut microbiome derived-metabolites in diabetic chronic kidney disease: An integrated approach using network pharmacology and molecular docking, Saudi Journal of Biological Sciences. 2024; 31: 104028104028.
https://doi.org/10.1016/j.sjbs.2024.104028 |
| 5 |
2024 |
Hua Miao, Fei Liu, Yan-Ni Wang, Xiao-Yong Yu, Shougang Zhuang, Yan Guo, Nosratola D. Vaziri, Shi-Xing Ma, Wei Su, You-Quan Shang, Ming Gao, Jin-Hua Zhang, Li Zhang, Ying-Yong Zhao, Gang Cao. Targeting Lactobacillus johnsonii to reverse chronic kidney disease, Signal Transduction and Targeted Therapy. 2024; 9: 195.
https://doi.org/10.1038/s41392-024-01913-1 |
| 6 |
2024 |
Hua Miao, Yan‐Ni Wang, Xiao‐Yong Yu, Liang Zou, Yan Guo, Wei Su, Fei Liu, Gang Cao, Ying‐Yong Zhao. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites, British Journal of Pharmacology. 2024; 181: 162.
https://doi.org/10.1111/bph.16219 |
| 7 |
2023 |
Jiali Fang, Yuhe Guo, Wei Yin, Lei Zhang, Guanghui Li, Junjie Ma, Lu Xu, Yunyi Xiong, Luhao Liu, Weiting Zhang, Zheng Chen. Neoxanthin alleviates the chronic renal failure-induced aging and fibrosis by regulating inflammatory process, International Immunopharmacology. 2023; 114: 109429109429.
https://doi.org/10.1016/j.intimp.2022.109429 |
| 8 |
2023 |
Li-Li Ren, Hua Miao, Yan-Ni Wang, Fei Liu, Ping Li, Ying-Yong Zhao. TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis, Aging and disease. 2023; 14: 1633.
https://doi.org/10.14336/AD.2023.0222 |
| 9 |
2023 |
Yiyou LIN, Jiale WEI, Yehui ZHANG, Junhao HUANG, Sichen WANG, Qihan LUO, Hongxia YU, Liting JI, Xiaojie ZHOU, Changyu LI. Shen Qi Wan attenuates renal interstitial fibrosis through upregulating AQP1, Chinese Journal of Natural Medicines. 2023; 21: 359.
https://doi.org/10.1016/S1875-5364(23)60453-4 |
| 10 |
2024 |
Hua Miao, Yan-ni Wang, Wei Su, Liang Zou, Shou-gang Zhuang, Xiao-yong Yu, Fei Liu, Ying-yong Zhao. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway, Acta Pharmacologica Sinica. 2024; 45: 137.
https://doi.org/10.1038/s41401-023-01148-w |
| 11 |
2023 |
Xiaoqiang Wu, Xiangyong Tian, Guanghui Cao, Zhiwei Wang, Xuan Wu, Yue Gu, Tianzhong Yan. Distinct profiles of bile acid metabolism caused by gut microbiota in kidney transplantation recipients revealed by 16S rRNA gene sequencing, Archives of Physiology and Biochemistry. 2023; 1.
https://doi.org/10.1080/13813455.2023.2212331 |
| 12 |
2024 |
Xia-Qing Wu, Lei Zhao, Yan-Long Zhao, Xin-Yao He, Liang Zou, Ying-Yong Zhao, Xia Li. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota, Pharmaceutical Biology. 2024; 62: 423.
https://doi.org/10.1080/13880209.2024.2351946 |
